ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype
Authors:
- 12 February 2014
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 31 (3) , 864
Abstract
Breast cancer stem cells are thought to be associated with metastasis and poor prognosis, but their clinical importance remains poorly understood. The aim of this study was to investigate whether certain phenotypes of breast cancer stem cells were clinically important factors regarding metastasis. Patients with primary breast cancer (n = 121) were included in this study. Breast cancer stem cells were identified by immunohistochemical staining of CD44, CD24, and aldehyde dehydrogenase 1 (ALDH1) in tumor tissues from primary and recurrent or metastatic lesions. CD44+/CD24− cells and ALDH1+ cells were considered breast cancer stem cells. Sixty-five patients had metastatic or recurrent tumors. ALDH1+ tumors were significantly associated with a high rate of metastasis or recurrence (63.1 %; P = 0.026). Although there was no significant association between the proportion of CD44+/CD24− tumor cells and metastasis rates, a high proportion of CD44+/CD24− tumor cells was a risk factor for metastasis or recurrence (P = 0.035). Changes in the proportion of CD44+/CD24− or ALDH1+ tumor cells between primary lesions and recurrent lesions were studied in 27 patients. The proportion of ALDH1+ tumor cells increased significantly (P = 0.019) after recurrence, but the proportion of CD44+/CD24− tumor cells did not. Our findings suggest that ALDH1+ and CD44+/CD24− breast cancer stem cells play significant roles in metastasis. The rate of ALDH1+ cells appears to be a better predictive marker of breast cancer metastasis than the CD44+/CD24− phenotype.Keywords
This publication has 21 references indexed in Scilit:
- Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer NetworkCancer, 2012
- ALDHhigh adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasisBiochemical and Biophysical Research Communications, 2010
- Breast Cancer Subtypes and the Risk of Local and Regional RelapseJournal of Clinical Oncology, 2010
- Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironmentBreast Cancer Research and Treatment, 2009
- Equivalence of Protein Inventories Obtained from Formalin-fixed Paraffin-embedded and Frozen Tissue in Multidimensional Liquid Chromatography-Tandem Mass Spectrometry Shotgun Proteomic AnalysisMolecular & Cellular Proteomics, 2009
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic abilityJournal of Cellular and Molecular Medicine, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer CellsNew England Journal of Medicine, 2007
- A human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003